Australia markets closed

Aerovate Therapeutics, Inc. (AVTE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.4500-0.0500 (-3.33%)
At close: 04:00PM EDT
1.4600 +0.01 (+0.69%)
Pre-market: 05:26AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
70,811
64,219
38,622
14,987
7,940
-
Selling general and administrative
17,577
17,190
14,615
8,035
949
-
Total operating expenses
88,388
81,409
53,237
23,022
8,889
-
Operating income or loss
-88,388
-81,409
-53,237
-23,022
-8,889
-
Interest expense
-
-
-
-
75
0
Total other income/expenses net
-3
-1
-79
-3
-647
-
Income before tax
-82,131
-75,465
-51,486
-22,960
-9,611
-
Income tax expense
-
56
25
3
0
-
Income from continuing operations
-82,187
-75,521
-51,511
-22,963
-9,611
-
Net income
-82,187
-75,521
-51,511
-22,963
-9,611
-
Net income available to common shareholders
-82,187
-75,521
-51,511
-22,985
-9,764
-
Basic EPS
-2.74
-
-2.10
-1.87
-40.17
-1.40
Diluted EPS
-2.74
-
-2.10
-1.87
-40.17
-1.40
Basic average shares
25,557
-
24,472
12,294
243.076
2,375
Diluted average shares
25,557
-
24,472
12,294
243.076
2,375